|
Born in Nigeria, Ovbiagele came to the United States in 1995
to pursue specialist training in stroke, the second-leading killer of Africans
and the single most deadly neurological disease. He plans to return to Nigeria in
the future to set up stroke centers.. He also hopes to help train new African
doctors and medical researchers.
Bruce Ovbiagele, a vascular neurologist, is assistant
professor of neurology at the University of California, Los Angeles. Among
other responsibilities, Dr. Ovbiagele directs the UCLA PROTECT program, which helps
hospitals provide the highest-quality stroke treatment to patients. He is a
national spokesperson for the American Heart Association and the American
Stroke Association's "Power to End Stroke" campaign.
Bruce Ovbiagele, MD, is Director of the Olive View-UCLA
Stroke Program, and Assistant Professor of Neurology at the University of
California, Los Angeles (UCLA). Dr. Ovbiagele heads the UCLA Stroke
Prevention Program, part of which comprises the UCLA PROTECT (Preventing
Recurrent Thromboembolic Events through Coordinated Treatment) initiative: an
innovative hospital-based quality improvement project aimed at improving the
utilization of medication and behavioral interventions known to reduce the risk
of stroke. He is a Vascular Neurologist, who is involved in research aimed at discovering effective vascular risk
reduction therapies in stroke, and developing innovative strategies for optimizing
the adherence to secondary stroke
prevention therapies.
Dr. Ovbiagele was Co-Chair of the 2006 NIH Stroke Progress
Review: Prevention of First and Recurrent Stroke Working Group. He serves on
several American Stroke Association (ASA) committees at the local, state and
national levels, and is a member of the American Heart Association (AHA) Stroke
Advisory Committee, a leadership body within the AHA, which advises the AHA on
national stroke policy and advocacy issues. He is also a national spokesperson
for the AHA, and is involved in conveying the implications of important new
stroke studies to the general public through the media. Most recently, he
became national medical spokesperson for the ASA "Power to End
Stroke" campaign, which is an
educational campaign geared at raising awareness about the warning
signs, prevention and treatment of stroke in the African American community.
Dr. Ovbiagele serves as the Principal Investigator for
two clinical research to clinical
practice trials, and a trial looking at the effects of intensive statin therapy
on carotid plaque morphology. He is also the site Principal Investigator for a
NINDS-funded stroke prevention study, a large-scale secondary stroke prevention
study, as well as a Co-Investigator in several multi-center trials in acute
stroke treatment and improved stroke imaging. Dr. Ovbiagele has authored or co-authored
over 60 publications, and over 75
abstracts.
--
The mission of NSBE is to increase the number of culturally responsible Black engineers who excel academically, succeed professionally, and positively impact the community.
| 
